-
admin
Posts
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
PDUFA Action Date for the Arimoclomol NDA is September 21, 2024 CELEBRATION, Fla., Aug. 02, 2024 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra,...
Avicanna Announces Changes of Auditors
TORONTO, Aug. 02, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the...
Digicann Ventures and 3Win Corp. Sign Binding LOI for Proposed RTO Transaction
/Not for distribution to U.S. news wire services or for dissemination in the United States/ VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) — Digicann...
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and monthly subcutaneous administration of TOUR006...
Transforming Women’s Health: Cross-Industry Impact and Innovations Report
Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) — The “Transforming Women’s Health: Cross-Industry Impact and Innovation” report has been added to ResearchAndMarkets.com’s offering. The evolution of...
Citronella Oil Market Size to Worth USD 793.03 Million by 2033
The global citronella oil market is anticipated to grow from USD 474.96 million to USD 793.03 million in 10 years. The growth of global health...
Certified Arborists in Austin, TX, Wilder Tree Company, Introduces Microbial Soil Conditioning to Enhance Tree Health
Wilder Tree Company introduces microbial soil conditioning to harness the power of beneficial microorganisms for eco-friendly arboriculture. Austin, TX, Aug. 01, 2024 (GLOBE NEWSWIRE) —...
MediWound to Report Second Quarter 2024 Financial Results
Conference Call and Webcast Scheduled for Wednesday, August 14th at 8:30 am Eastern Time YAVNE, Israel, Aug. 02, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq:...
Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET
HOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2024...
23andMe Special Committee responds to CEO’s take-private proposal
SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) — The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME), a...